| Covid-19 and disparities in nutrition and obesity MJ Belanger, MA Hill, AM Angelidi, M Dalamaga, JR Sowers, ... New England Journal of Medicine 383 (11), e69, 2020 | 250 | 2020 |
| Mediterranean diet as a nutritional approach for COVID-19 AM Angelidi, A Kokkinos, E Katechaki, E Ros, CS Mantzoros Metabolism-Clinical and Experimental 114, 2021 | 110 | 2021 |
| Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next AM Angelidi, MJ Belanger, CS Mantzoros Metabolism-Clinical and Experimental 107, 2020 | 107 | 2020 |
| Vitamin D status is associated with in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients AM Angelidi, MJ Belanger, MK Lorinsky, D Karamanis, ... Mayo Clinic Proceedings 96 (4), 875-886, 2021 | 93 | 2021 |
| Novel noninvasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy AM Angelidi, MJ Belanger, A Kokkinos, CC Koliaki, CS Mantzoros Endocrine reviews 43 (3), 507-557, 2022 | 64 | 2022 |
| Deep transfer learning and data augmentation improve glucose levels prediction in type 2 diabetes patients Y Deng, L Lu, L Aponte, AM Angelidi, V Novak, GE Karniadakis, ... NPJ Digital Medicine 4 (1), 109, 2021 | 64 | 2021 |
| Severe insulin resistance syndromes AM Angelidi, A Filippaios, CS Mantzoros The Journal of Clinical Investigation 131 (4), 2021 | 58 | 2021 |
| Diagnostic modalities of non-alcoholic fatty liver disease: from biochemical biomarkers to multi-omics non-invasive approaches E Martinou, M Pericleous, I Stefanova, V Kaur, AM Angelidi Diagnostics 12 (2), 407, 2022 | 39 | 2022 |
| Is atorvastatin associated with new onset diabetes or deterioration of glycemic control? Systematic review using data from 1.9 million patients AM Angelidi, E Stambolliu, KI Adamopoulou, AA Kousoulis International journal of endocrinology 2018, 2018 | 37 | 2018 |
| The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials AM Angelidi, A Papadaki, E Nolen-Doerr, C Boutari, CS Mantzoros Metabolism 129, 155136, 2022 | 24 | 2022 |
| Neurohormonal changes in the gut–brain axis and underlying neuroendocrine mechanisms following bariatric surgery E Martinou, I Stefanova, E Iosif, AM Angelidi International journal of molecular sciences 23 (6), 3339, 2022 | 24 | 2022 |
| Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals I Protopsaltis, S Foussas, A Angelidi, A Gritzapis, TΝ Sergentanis, ... Cardiovascular diabetology 11, 1-9, 2012 | 20 | 2012 |
| Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity AM Angelidi, A Kokkinos, D Sanoudou, MA Connelly, A Alexandrou, ... Metabolism 138, 155346, 2023 | 15 | 2023 |
| HOXB9 Overexpression Promotes Colorectal Cancer Progression and Is Associated with Worse Survival in Liver Resection Patients for Colorectal Liver Metastases E Martinou, C Moller-Levet, D Karamanis, I Bagwan, AM Angelidi International journal of molecular sciences 23 (4), 2281, 2022 | 11 | 2022 |
| Endothelial progenitor cells as a cardiometabolic risk factor marker in prediabetes A Angelidi, A Melidonis, I Protopsaltis, TN Sergentanis, A Gritzapis, ... Hormones 13, 244-251, 2014 | 11 | 2014 |
| The impact of continuous subcutaneous insulin infusion therapy on efficacy and safety in a cohort of type 1 diabetes patients: a 3-year prospective study A Melidonis, A Kamaratos, A Angelidi, P Thomakos, S Vrakas, J Bakalis, ... Diabetes Technology & Therapeutics 18 (3), 159-163, 2016 | 9 | 2016 |
| Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized … N Perakakis, B Kalra, AM Angelidi, A Kumar, A Gavrieli, M Yannakoulia, ... Metabolism 129, 155157, 2022 | 8 | 2022 |
| Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and Lp (a) in diabetes: A cross-sectional study S Antonopoulos, M Mylonopoulou, AM Angelidi, AA Kousoulis, ... Diabetes research and clinical practice 130, 252-257, 2017 | 8 | 2017 |
| PBX4 functions as a potential novel oncopromoter in colorectal cancer: a comprehensive analysis of the PBX gene family EG Martinou, CS Moller-Levet, AM Angelidi American journal of cancer research 12 (2), 585, 2022 | 7 | 2022 |
| Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and … N Perakakis, A Kokkinos, AM Angelidi, D Tsilingiris, A Gavrieli, ... Clinical Nutrition 41 (9), 1969-1976, 2022 | 6 | 2022 |
